Fig. 4From: Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysisGSEA analysis demonstrating most enriched gene sets between the healthy and IgAN group. (A) The most significant enriched gene set was proteasome pathway (ES = 0.666, NES = 1.782, p < 0.05). (B) The second significant enriched gene set was allograft rejection (ES = 0.707, NES = 1.586, p < 0.05). (C) The third significant enriched gene set was viral myocarditis (ES = 0.548, NES = 1.568, p < 0.05). (D) The fourth significant enriched gene set was graft versus host disease (ES = 0.685, NES = 1.568, p < 0.05). (E) The fifth significant enriched gene set was FCγR mediated phagocytosis (ES = 0.524, NES = 1.562, p < 0.05). (F) The sixth significant enriched gene set was natural killer cell mediated cytotoxicity. (ES = 0.543, NES = 1.534, p < 0.05). GSEA: gene set enrichment analysis; ES: enrichment score; NES: normalized enrichment score; IgAN: IgA nephropathyBack to article page